CN Stock MarketDetailed Quotes

688617 APT Medical Inc.

Watchlist
  • 416.12
  • -7.83-1.85%
Market Closed Apr 30 15:00 CST
40.40BMarket Cap56.41P/E (TTM)

APT Medical Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
Total operating revenue
23.93%564.28M
25.18%2.07B
25.63%1.52B
27.03%1B
30.20%455.33M
35.71%1.65B
36.78%1.21B
41.81%787.99M
31.71%349.71M
46.74%1.22B
Operating revenue
23.93%564.28M
25.18%2.07B
25.63%1.52B
27.03%1B
30.20%455.33M
35.71%1.65B
36.78%1.21B
41.81%787.99M
31.71%349.71M
46.74%1.22B
Total operating cost
15.95%357.74M
19.99%1.34B
18.07%970.56M
21.59%636.1M
24.46%308.52M
32.23%1.12B
30.30%822M
29.93%523.17M
23.87%247.89M
30.18%843.95M
Operating cost
19.18%151.86M
20.62%571.96M
19.87%416.43M
22.47%272.79M
24.21%127.42M
35.42%474.18M
34.95%347.39M
35.31%222.73M
27.83%102.59M
38.49%350.17M
Operating tax surcharges
19.71%6.98M
22.51%24.71M
17.82%18.41M
17.48%12.3M
26.40%5.83M
43.89%20.17M
45.67%15.62M
59.32%10.47M
29.71%4.61M
65.11%14.02M
Operating expense
11.64%98.07M
22.36%372.82M
16.05%270.4M
17.55%177.19M
26.91%87.85M
26.42%304.7M
29.99%233.01M
36.12%150.74M
26.26%69.22M
22.78%241.03M
Administration expense
25.28%30.39M
11.26%91.52M
8.77%67.59M
30.43%46.29M
35.71%24.26M
23.61%82.26M
18.99%62.14M
5.51%35.49M
2.77%17.87M
20.73%66.55M
Financial expense
-43.75%-3.54M
-284.90%-12.53M
-14.40%-5.12M
-22.65%-6.37M
-350.74%-2.46M
-21.10%-3.26M
-45.84%-4.48M
-310.88%-5.19M
345.98%982.21K
-519.14%-2.69M
-Interest expense (Financial expense)
63.44%1.17M
-45.64%2.01M
-48.96%1.57M
-51.29%1.08M
-48.86%713.21K
154.09%3.69M
135.46%3.08M
110.82%2.22M
258.67%1.39M
-10.73%1.45M
-Interest Income (Financial expense)
-25.46%-3.93M
-161.90%-12.06M
-189.26%-9.41M
-201.61%-6.59M
-287.87%-3.13M
-44.37%-4.61M
-42.46%-3.25M
-29.09%-2.18M
15.98%-807.42K
-47.87%-3.19M
Research and development
12.73%73.97M
22.12%290.54M
20.52%202.86M
22.92%133.89M
24.73%65.62M
36.05%237.92M
25.31%168.32M
23.26%108.93M
18.26%52.61M
29.66%174.88M
Credit Impairment Loss
-1,784.33%-846.91K
-678.99%-2.69M
-2,448.15%-1.18M
-198.22%-870.24K
-108.04%-44.94K
144.01%464.86K
95.23%-46.41K
266.75%886.01K
318.76%558.72K
-678.55%-1.06M
Asset Impairment Loss
-210.23%-99.29K
-55.83%-24.63M
-146.98%-1.95M
-319.34%-1.91M
-89.21%90.08K
-8.70%-15.8M
1,012.01%4.14M
414.23%871.36K
288.78%834.99K
-49.25%-14.54M
Other net revenue
Fair value change income
----
----
-54.59%1.47M
-39.65%867.79K
-53.38%897.6K
----
117.28%3.23M
108.17%1.44M
110.16%1.93M
-98.43%341.8K
Invest income
34.30%4.49M
-43.06%13.17M
-30.58%11.48M
-50.11%7.27M
7,555.76%3.35M
11.48%23.13M
-59.33%16.54M
-56.65%14.57M
-99.84%43.71K
86.85%20.75M
-Including: Investment income associates
30.63%2.99M
230.20%5.38M
305.88%6.86M
274.00%4.3M
170.44%2.29M
12.77%-4.13M
-339.52%-3.33M
-252.56%-2.47M
-447.90%-3.25M
-381.21%-4.73M
Asset deal income
49.71%-350.61
-97.88%253.32K
-99.64%43.59K
-67.27%22.82K
-101.00%-697.13
21,186.54%11.97M
20,828.95%11.96M
423.74%69.72K
422.58%69.57K
239.10%56.21K
Other revenue
-18.91%5.58M
-12.10%40.8M
-8.35%25.18M
104.47%19.54M
-34.86%6.89M
139.66%46.41M
128.74%27.47M
38.96%9.56M
970.25%10.57M
2.92%19.37M
Operating profit
36.51%215.67M
25.53%753.69M
29.52%589.31M
33.39%389.78M
36.39%157.98M
51.24%600.41M
56.95%455.01M
66.48%292.21M
56.24%115.83M
78.42%396.99M
Add:Non operating Income
-91.97%3.98K
-54.60%281.89K
-82.78%106.42K
831.06%119.83K
284.63%49.5K
-60.11%620.91K
-61.16%618.16K
-99.15%12.87K
515.65%12.87K
3,491.76%1.56M
Less:Non operating expense
426.32%1.85M
71.52%8.01M
78.94%2.65M
59.53%1.63M
92.50%352.14K
36.76%4.67M
4.87%1.48M
-14.94%1.02M
17,258.61%182.93K
244.01%3.41M
Total profit
35.60%213.82M
25.09%745.97M
29.20%586.77M
33.33%388.27M
36.33%157.68M
50.93%596.37M
56.55%454.15M
65.60%291.2M
56.01%115.66M
78.35%395.13M
Less:Income tax cost
69.93%33.68M
18.27%87.8M
12.38%64.72M
30.20%50.21M
17.46%19.82M
35.04%74.24M
35.67%57.59M
45.14%38.57M
51.77%16.88M
105.89%54.98M
Net profit
30.67%180.14M
26.05%658.17M
31.64%522.05M
33.81%338.06M
39.56%137.86M
53.50%522.13M
60.13%396.56M
69.25%252.63M
56.75%98.78M
74.57%340.16M
Net profit from continuing operation
30.67%180.14M
26.05%658.17M
31.64%522.05M
33.81%338.06M
39.56%137.86M
53.50%522.13M
60.13%396.56M
69.25%252.63M
56.75%98.78M
74.57%340.16M
Less:Minority Profit
-32.05%-3.02M
-27.05%-14.98M
8.80%-6.1M
5.39%-4.5M
41.47%-2.28M
33.98%-11.79M
48.30%-6.68M
50.43%-4.76M
-3.03%-3.9M
-36.67%-17.86M
Net profit of parent company owners
30.69%183.15M
26.08%673.15M
30.97%528.15M
33.09%342.56M
36.48%140.14M
49.13%533.92M
54.75%403.25M
62.01%257.4M
53.71%102.69M
72.19%358.02M
Earning per share
Basic earning per share
30.34%1.89
25.63%6.96
30.77%5.44
32.64%5.12
-5.84%1.45
2.97%5.54
6.39%4.16
62.18%3.86
54.00%1.54
68.65%5.38
Diluted earning per share
30.56%1.88
26.74%6.92
31.55%5.42
34.21%5.1
-5.26%1.44
3.02%5.46
7.01%4.12
61.70%3.8
53.54%1.52
67.19%5.3
Other composite income
-264.43%-138.08K
-391.40%-22.58M
-25.35%10.59M
-25.77%10.58M
79.93%-37.89K
-16.95%7.75M
264.31%14.19M
289.40%14.26M
-1,959.95%-188.8K
-47.88%9.33M
Other composite income of parent company owners
-264.43%-138.08K
-372.77%-21.13M
-19.42%11.43M
-19.87%11.43M
79.93%-37.89K
-16.95%7.75M
264.31%14.19M
289.40%14.26M
-1,959.95%-188.8K
-47.88%9.33M
Other composite income of minority owners
----
---1.44M
---841.17K
---841.17K
----
----
----
----
----
----
Total composite income
30.60%180M
19.95%635.59M
29.67%532.64M
30.63%348.64M
39.79%137.82M
51.62%529.88M
63.29%410.75M
74.52%266.89M
56.48%98.6M
64.27%349.48M
Total composite income of parent company owners
30.63%183.01M
20.37%652.02M
29.26%539.58M
30.31%353.99M
36.69%140.11M
47.45%541.67M
57.84%417.44M
67.14%271.66M
53.45%102.5M
62.67%367.35M
Total composite income of minority owners
-32.05%-3.02M
-39.28%-16.43M
-3.79%-6.94M
-12.28%-5.35M
41.47%-2.28M
33.98%-11.79M
48.30%-6.68M
50.43%-4.76M
-3.03%-3.9M
-36.67%-17.86M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
--
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022
Total operating revenue 23.93%564.28M25.18%2.07B25.63%1.52B27.03%1B30.20%455.33M35.71%1.65B36.78%1.21B41.81%787.99M31.71%349.71M46.74%1.22B
Operating revenue 23.93%564.28M25.18%2.07B25.63%1.52B27.03%1B30.20%455.33M35.71%1.65B36.78%1.21B41.81%787.99M31.71%349.71M46.74%1.22B
Total operating cost 15.95%357.74M19.99%1.34B18.07%970.56M21.59%636.1M24.46%308.52M32.23%1.12B30.30%822M29.93%523.17M23.87%247.89M30.18%843.95M
Operating cost 19.18%151.86M20.62%571.96M19.87%416.43M22.47%272.79M24.21%127.42M35.42%474.18M34.95%347.39M35.31%222.73M27.83%102.59M38.49%350.17M
Operating tax surcharges 19.71%6.98M22.51%24.71M17.82%18.41M17.48%12.3M26.40%5.83M43.89%20.17M45.67%15.62M59.32%10.47M29.71%4.61M65.11%14.02M
Operating expense 11.64%98.07M22.36%372.82M16.05%270.4M17.55%177.19M26.91%87.85M26.42%304.7M29.99%233.01M36.12%150.74M26.26%69.22M22.78%241.03M
Administration expense 25.28%30.39M11.26%91.52M8.77%67.59M30.43%46.29M35.71%24.26M23.61%82.26M18.99%62.14M5.51%35.49M2.77%17.87M20.73%66.55M
Financial expense -43.75%-3.54M-284.90%-12.53M-14.40%-5.12M-22.65%-6.37M-350.74%-2.46M-21.10%-3.26M-45.84%-4.48M-310.88%-5.19M345.98%982.21K-519.14%-2.69M
-Interest expense (Financial expense) 63.44%1.17M-45.64%2.01M-48.96%1.57M-51.29%1.08M-48.86%713.21K154.09%3.69M135.46%3.08M110.82%2.22M258.67%1.39M-10.73%1.45M
-Interest Income (Financial expense) -25.46%-3.93M-161.90%-12.06M-189.26%-9.41M-201.61%-6.59M-287.87%-3.13M-44.37%-4.61M-42.46%-3.25M-29.09%-2.18M15.98%-807.42K-47.87%-3.19M
Research and development 12.73%73.97M22.12%290.54M20.52%202.86M22.92%133.89M24.73%65.62M36.05%237.92M25.31%168.32M23.26%108.93M18.26%52.61M29.66%174.88M
Credit Impairment Loss -1,784.33%-846.91K-678.99%-2.69M-2,448.15%-1.18M-198.22%-870.24K-108.04%-44.94K144.01%464.86K95.23%-46.41K266.75%886.01K318.76%558.72K-678.55%-1.06M
Asset Impairment Loss -210.23%-99.29K-55.83%-24.63M-146.98%-1.95M-319.34%-1.91M-89.21%90.08K-8.70%-15.8M1,012.01%4.14M414.23%871.36K288.78%834.99K-49.25%-14.54M
Other net revenue
Fair value change income ---------54.59%1.47M-39.65%867.79K-53.38%897.6K----117.28%3.23M108.17%1.44M110.16%1.93M-98.43%341.8K
Invest income 34.30%4.49M-43.06%13.17M-30.58%11.48M-50.11%7.27M7,555.76%3.35M11.48%23.13M-59.33%16.54M-56.65%14.57M-99.84%43.71K86.85%20.75M
-Including: Investment income associates 30.63%2.99M230.20%5.38M305.88%6.86M274.00%4.3M170.44%2.29M12.77%-4.13M-339.52%-3.33M-252.56%-2.47M-447.90%-3.25M-381.21%-4.73M
Asset deal income 49.71%-350.61-97.88%253.32K-99.64%43.59K-67.27%22.82K-101.00%-697.1321,186.54%11.97M20,828.95%11.96M423.74%69.72K422.58%69.57K239.10%56.21K
Other revenue -18.91%5.58M-12.10%40.8M-8.35%25.18M104.47%19.54M-34.86%6.89M139.66%46.41M128.74%27.47M38.96%9.56M970.25%10.57M2.92%19.37M
Operating profit 36.51%215.67M25.53%753.69M29.52%589.31M33.39%389.78M36.39%157.98M51.24%600.41M56.95%455.01M66.48%292.21M56.24%115.83M78.42%396.99M
Add:Non operating Income -91.97%3.98K-54.60%281.89K-82.78%106.42K831.06%119.83K284.63%49.5K-60.11%620.91K-61.16%618.16K-99.15%12.87K515.65%12.87K3,491.76%1.56M
Less:Non operating expense 426.32%1.85M71.52%8.01M78.94%2.65M59.53%1.63M92.50%352.14K36.76%4.67M4.87%1.48M-14.94%1.02M17,258.61%182.93K244.01%3.41M
Total profit 35.60%213.82M25.09%745.97M29.20%586.77M33.33%388.27M36.33%157.68M50.93%596.37M56.55%454.15M65.60%291.2M56.01%115.66M78.35%395.13M
Less:Income tax cost 69.93%33.68M18.27%87.8M12.38%64.72M30.20%50.21M17.46%19.82M35.04%74.24M35.67%57.59M45.14%38.57M51.77%16.88M105.89%54.98M
Net profit 30.67%180.14M26.05%658.17M31.64%522.05M33.81%338.06M39.56%137.86M53.50%522.13M60.13%396.56M69.25%252.63M56.75%98.78M74.57%340.16M
Net profit from continuing operation 30.67%180.14M26.05%658.17M31.64%522.05M33.81%338.06M39.56%137.86M53.50%522.13M60.13%396.56M69.25%252.63M56.75%98.78M74.57%340.16M
Less:Minority Profit -32.05%-3.02M-27.05%-14.98M8.80%-6.1M5.39%-4.5M41.47%-2.28M33.98%-11.79M48.30%-6.68M50.43%-4.76M-3.03%-3.9M-36.67%-17.86M
Net profit of parent company owners 30.69%183.15M26.08%673.15M30.97%528.15M33.09%342.56M36.48%140.14M49.13%533.92M54.75%403.25M62.01%257.4M53.71%102.69M72.19%358.02M
Earning per share
Basic earning per share 30.34%1.8925.63%6.9630.77%5.4432.64%5.12-5.84%1.452.97%5.546.39%4.1662.18%3.8654.00%1.5468.65%5.38
Diluted earning per share 30.56%1.8826.74%6.9231.55%5.4234.21%5.1-5.26%1.443.02%5.467.01%4.1261.70%3.853.54%1.5267.19%5.3
Other composite income -264.43%-138.08K-391.40%-22.58M-25.35%10.59M-25.77%10.58M79.93%-37.89K-16.95%7.75M264.31%14.19M289.40%14.26M-1,959.95%-188.8K-47.88%9.33M
Other composite income of parent company owners -264.43%-138.08K-372.77%-21.13M-19.42%11.43M-19.87%11.43M79.93%-37.89K-16.95%7.75M264.31%14.19M289.40%14.26M-1,959.95%-188.8K-47.88%9.33M
Other composite income of minority owners -------1.44M---841.17K---841.17K------------------------
Total composite income 30.60%180M19.95%635.59M29.67%532.64M30.63%348.64M39.79%137.82M51.62%529.88M63.29%410.75M74.52%266.89M56.48%98.6M64.27%349.48M
Total composite income of parent company owners 30.63%183.01M20.37%652.02M29.26%539.58M30.31%353.99M36.69%140.11M47.45%541.67M57.84%417.44M67.14%271.66M53.45%102.5M62.67%367.35M
Total composite income of minority owners -32.05%-3.02M-39.28%-16.43M-3.79%-6.94M-12.28%-5.35M41.47%-2.28M33.98%-11.79M48.30%-6.68M50.43%-4.76M-3.03%-3.9M-36.67%-17.86M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion------Unqualified opinion
Auditor ----------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
CG MED EQUIP.
838810
+29.98%
BEOKA
870199
+29.96%
Shenzhen Bromake New Material
301387
+20.01%
4
Zhejiang Hongchang Electrical Technology
301008
+20.00%
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
+20.00%
Log In for the Full List
Unlock Now